TherapeuticsMD, Inc. (TXMD)
2.21
-0.03
(-1.34%)
USD |
NASDAQ |
Sep 04, 16:00
2.17
-0.04
(-1.81%)
After-Hours: 20:00
TherapeuticsMD Profit Margin (Quarterly) : 18.87% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.87% |
| March 31, 2026 | 14.23% |
| December 31, 2025 | -68.53% |
| September 30, 2025 | 6.38% |
| June 30, 2025 | 57.25% |
| March 31, 2025 | -161.8% |
| December 31, 2024 | 17.09% |
| September 30, 2024 | -103.7% |
| June 30, 2024 | -448.7% |
| March 31, 2024 | -258.5% |
| December 31, 2023 | -307.0% |
| September 30, 2023 | |
| June 30, 2023 | -552.4% |
| March 31, 2023 | -555.3% |
| September 30, 2022 | -4.13K% |
| June 30, 2022 | -4.27K% |
| March 31, 2022 | -2.57K% |
| December 31, 2021 | -230.0% |
| September 30, 2021 | -186.6% |
| June 30, 2021 | -185.4% |
| March 31, 2021 | -198.2% |
| December 31, 2020 | -186.4% |
| September 30, 2020 | -168.6% |
| June 30, 2020 | -485.7% |
| March 31, 2020 | -464.0% |
| Date | Value |
|---|---|
| December 31, 2019 | -310.9% |
| September 30, 2019 | -134.8% |
| June 30, 2019 | -908.7% |
| March 31, 2019 | -1.00K% |
| December 31, 2018 | -774.0% |
| September 30, 2018 | -1.03K% |
| June 30, 2018 | -882.8% |
| March 31, 2018 | -646.7% |
| December 31, 2017 | -519.6% |
| September 30, 2017 | -332.0% |
| June 30, 2017 | -462.9% |
| March 31, 2017 | -530.8% |
| December 31, 2016 | -508.9% |
| September 30, 2016 | -451.9% |
| June 30, 2016 | -479.1% |
| March 31, 2016 | -424.5% |
| December 31, 2015 | -310.5% |
| September 30, 2015 | -375.2% |
| June 30, 2015 | -561.6% |
| March 31, 2015 | -466.9% |
| December 31, 2014 | -382.9% |
| September 30, 2014 | -426.0% |
| June 30, 2014 | -290.5% |
| March 31, 2014 | -324.4% |
| December 31, 2013 | -292.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.09% |
| Return on Assets | -0.78% |
| Return on Invested Capital | -0.89% |
| Gross Profit Margin (Quarterly) | 62.14% |
| Operating Margin (Quarterly) | -92.41% |
| Return on Net Operating Assets | -3.06% |